From: PAGED: a pathway and gene-set enrichment database to enable molecular phenotype discoveries
Gene-set Name | Hits | P value | FDR | Data Source |
---|---|---|---|---|
Molecular Mechanisms of Cancer | 38 | 2.48E-17 | 7.04E-10 | Protein Lounge |
PI3K Signaling | 33 | 2.01E-13 | 7.04E-10 | Protein Lounge |
Akt Signaling | 27 | 9.6E-13 | 7.04E-10 | Protein Lounge |
ERK Signaling | 24 | 1.53E-10 | 7.04E-10 | Protein Lounge |
GSK3 Signaling | 23 | 1.32E-13 | 7.04E-10 | Protein Lounge |
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages | 9 | 3.7E-11 | 7.04E-10 | BioCarta |
atm signaling pathway | 8 | 6.28E-11 | 7.04E-10 | BioCarta |
wnt signaling pathway | 7 | 7.7E-09 | 7.04E-10 | BioCarta |
cell cycle: g2/m checkpoint | 7 | 2.14E-08 | 7.04E-10 | BioCarta |
cell cycle: g1/s check point | 7 | 2.14E-08 | 7.04E-10 | BioCarta |
Canonical Wnt signaling pathway | 8 | 9.24E-10 | 7.04E-10 | NCI-Nature |
Presenilin action in Notch and Wnt signaling | 8 | 3.16E-08 | 7.04E-10 | NCI-Nature |
Plasma membrane estrogen receptor signaling | 7 | 1.41E-08 | 7.04E-10 | NCI-Nature |
FOXM1 transcription factor network | 7 | 2.48E-07 | 7.04E-10 | NCI-Nature |
LPA receptor mediated events | 7 | 1.45E-06 | 7.04E-10 | NCI-Nature |
Metabolism of xenobiotics by cytochrome P450 | 20 | 3.3E-25 | 7.04E-10 | KEGG |
Drug metabolism - cytochrome P450 | 17 | 4.96E-21 | 7.04E-10 | KEGG |
Bladder cancer | 15 | 3.29E-18 | 7.04E-10 | KEGG |
Cytokine-cytokine receptor interaction | 15 | 1.39E-06 | 7.04E-10 | KEGG |
Colorectal cancer | 14 | 4.43E-14 | 7.04E-10 | KEGG |
p53 signaling pathway | 14 | 4.92E-14 | 7.04E-10 | KEGG |
Prostate cancer | 14 | 1.66E-12 | 7.04E-10 | KEGG |
Xenobiotics | 5 | 3.32E-08 | 7.04E-10 | Reactome |
Formation of incision complex in GG-NER | 5 | 5.75E-06 | 7.04E-10 | Reactome |
Global Genomic NER (GG-NER) | 5 | 5.75E-06 | 7.04E-10 | Reactome |
Dual incision reaction in GG-NER | 5 | 5.75E-06 | 7.04E-10 | Reactome |
Exocytosis of Alpha granule | 5 | 0.000217 | 1.95E-08 | Reactome |
SIGNAL_TRANSDUCTION | 55 | 8.36E-28 | 7.04E-10 | MsigDB |
BIOPOLYMER_METABOLIC_PROCESS | 49 | 4.16E-22 | 7.04E-10 | MsigDB |
KEGG_PATHWAYS_IN_CANCER | 43 | 9.9E-46 | 7.04E-10 | MsigDB |
NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS | 41 | 2.16E-20 | 7.04E-10 | MsigDB |
NUCLEUS | 41 | 1.8E-18 | 7.04E-10 | MsigDB |
Immune_Kong10_5640genes_ImmPort_ComprehensiveListofImmune-RelatedGenes | 114 | 3.61E-49 | 7.04E-10 | GeneSigDB |
Lymphoma_Melendez05_4229genes | 81 | 1.57E-39 | 7.04E-10 | GeneSigDB |
Breast_Farmer05_3198genes_basal_apocrine_luminal | 66 | 1.08E-21 | 7.04E-10 | GeneSigDB |
Ovarian_Crijns09_2394Genes_17PathwayPredictor | 57 | 7.94E-30 | 7.04E-10 | GeneSigDB |
StemCell_Nilsson07_3742genes | 45 | 4.86E-07 | 7.04E-10 | GeneSigDB |
hsa-miR-19a | 3 | 1.49E-05 | 8.43E-09 | miRecords |
[hsa-miR-21] | 3 | 0.000116 | 8.43E-09 | miRecords |
hsa-miR-204 | 3 | 0.000164 | 1.95E-08 | miRecords |
hsa-miR-21 | 3 | 0.000953 | 2.72E-07 | miRecords |
hsa-miR-125b | 3 | 0.003089 | 2.72E-07 | miRecords |